CJC-1295 without DAC + Ipamorelin

CJC-1295 without DAC + Ipamorelin, also published as CJC / IPA, is catalogued here as: CJC-1295 + Ipamorelin blend. This blend names CJC-1295 and ipamorelin. Long-acting CJC-1295 trial data cannot be assigned to a non-DAC or unspecified CJC component, or to the combination. This listing names CJC-1295, discussed as a long-acting analogue of growth-hormone-releasing hormone, together with ipamorelin, a pentapeptide described as a selective growth hormone secretagogue. They reach the same axis by different mechanisms. CJC without DAC + ipamorelin in one preparation: two different ingredients associated with growth-hormone signalling research. Evidence for the combination remains under review.

Each component has its own literature. Growth-hormone-axis research measures hormone and IGF-I responses, in short randomized studies in healthy adults for CJC-1295, and in cell, rat and swine preparations for ipamorelin.

Studies of long-acting CJC-1295 given alone in healthy adults reported prolonged stimulation of growth hormone and IGF-I secretion. Ipamorelin was characterised as a selective growth hormone secretagogue with receptor pharmacology resembling growth-hormone-releasing peptides.

Proof Line Peptides lists CJC-1295 without DAC + Ipamorelin as a vial in 10 mg, with pack sizes of 1, 3, 5 and 10. Prices are shown in Canadian dollars, and orders ship from Toronto by tracked Canadian service.

The matched PPB Analytical Inc. report for CJC-1295 without DAC + Ipamorelin 10 mg (report 2026030612-02, dated Mar. 27, 2026) records 100.00% purity. It documents the supplier sample sent for testing, not every shipped lot, and the original PDF is linked on this page.

Shipped lyophilized (freeze-dried) and stable at room temperature in transit. Store sealed vials in the fridge or freezer on arrival. Once reconstituted, refrigerate. Anything not right? Our guarantee covers it.